血管闭合装置市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPHE100001123
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 197
Buy Now

[研究报告]血管闭合装置市场预计将从2022年的16.2044亿美元增至2030年的28.0455亿美元。预计2022年至2030年市场复合年增长率为7.1%。
市场洞察和分析师观点:
血管闭合装置是一块胶原蛋白(一种存在于皮肤、结缔组织和骨骼中的纤维蛋白)、金属夹或缝合线,旨在闭合血管造影后动脉中产生的小刺孔。推动血管闭合装置市场增长的关键因素包括心血管疾病患病率的增加和对微创装置的需求不断增长。然而,与血管闭合装置相关的感染风险阻碍了市场增长。
增长动力和限制:
动脉粥样硬化、心绞痛和急性心肌梗塞等心血管疾病是世界范围内死亡的主要原因。根据世界卫生组织(WHO)提供的数据,心血管疾病每年导致近1790万人死亡,是所有非传染性疾病中的首要死因,其次是癌症、慢性呼吸道疾病和糖尿病(包括相关死亡)患有肾脏疾病)。根据世界心脏联合会的数据,高胆固醇每年导致 440 万人死亡,约 24% 的心血管相关死亡与高低密度脂蛋白 (LDL) 水平有关。根据 NCBI 2023 年 1 月发布的一项研究,美国 50 岁及以上人口数量很可能从 2020 年的 1.3725 亿增至 2050 年的 2.2113 亿。预计患有至少一种慢性疾病的人数将增加 99.5%,从 2020 年的 7152 万人增至 2050 年的 1.4266 万人。此外,到 2050 年,约 1400 万名 50 岁及以上的人可能患有合并症。
血管闭合装置(VCD) 提供了一种通过股动脉通路进行侵入性心血管治疗后提高患者舒适度和活动能力的新方法。这些装置用于不同的治疗方法,以提供简单、快速、可靠的止血效果。在美国,股动脉通路是经皮冠状动脉介入治疗 (PCI) 和冠状动脉造影最常用的血管通路技术。尽管如此,近年来通过桡动脉入路进行心导管插入术和经皮冠状动脉介入治疗(PCI)的趋势有所增加。已经开发了几种股动脉闭合装置来缩短血管闭合时间,在临床试验中观察到不同的血管并发症发生率。 VCD 已成为心导管插入术后传统机械压迫手术的有效替代方案。 VCD 减少了住院时间,加快了患者的活动速度,并缩短了止血所需的时间。因此,随着心血管疾病患病率的增加,血管闭合装置市场显着增长。
另一方面,与手动压迫相比,血管闭合装置更容易引起感染。腹股沟血肿是最常见的问题之一,在使用股动脉血管闭合装置时无法控制股动脉,导致鞘管去除后立即发生。当血管闭合装置失效时,必须手动加压以完成止血。腹股沟血肿是股骨入路最常见的并发症,发生血肿的患者应严格避免正常的体力活动。因此,腹股沟血肿可能会因并发症和住院时间延长而导致医疗费用增加。闭合装置的其他显着并发症包括肢体缺血和动脉切开部位远端缺血。远端肢体缺血通常是由于远端栓塞或血栓形成而发生,并且可能是由于放置闭合装置引起的,这在动脉严重钙化区域是禁忌的。与手动压迫相比,血管闭合装置中肢体缺血感染更常见。因此,感染风险在一定程度上阻碍了血管闭合装置市场的增长。
战略见解
报告细分和范围:
全球血管闭合装置市场根据产品类型进行细分、访问权限、过程和最终用户。根据产品类型,市场分为主动接近器、被动接近器和外部止血装置。血管闭合装置市场按通路分为股动脉通路和桡动脉通路。根据手术方式,市场分为介入放射学、介入心脏病学和血管内外科。就最终用户而言,血管闭合装置市场分为医院、门诊手术中心等。血管闭合装置市场根据地理位置分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本) 、印度、韩国和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷以及南美洲和非洲其他地区)中美洲)。
细分分析:
血管闭合装置市场按产品类型分为主动接近器、被动接近器和外部止血装置。无源逼近器细分市场在 2022 年占据最大市场份额,预计 2022 年至 2030 年期间复合年增长率将达到最高。被动接近器在动脉切开部位部署塞子、密封剂或凝胶,而不是通过主动机制将其关闭。与主动逼近器不同,被动逼近器一旦部署就不需要任何额外的闭合机构,例如缝合线或夹子。被动接近器通常由可生物降解或可吸收的组件组成,可促进自然凝血过程并促进穿刺部位形成稳定的血凝块。
血管闭合装置市场,按产品类型 - 2022 年和 2030 年
基于访问,血管闭合装置市场已细分为股动脉通路和桡动脉通路。股骨通路细分市场在 2022 年占据了更大的市场份额。桡动脉通路细分市场预计在 2022 年至 2030 年期间将实现更高的复合年增长率。股动脉通路涉及通过腹股沟区域的股动脉接入血管,而桡动脉通路涉及通过手腕的桡动脉接入血管。近年来,与股动脉入路相比,桡动脉入路因其具有降低并发症风险(包括出血和血肿)等优点而受到欢迎。
根据手术方式,血管闭合装置市场分为介入放射学、介入心脏病学和血管内手术。介入心脏病学领域在 2022 年占据最大的市场份额。然而,介入放射学领域预计在 2022 年至 2030 年期间将实现最高的市场复合年增长率。介入放射学 (IR) 是一门医学专业,它使用医学成像引导的微创技术来诊断和治疗各种病症。
根据最终用户,血管闭合装置市场分为医院、门诊手术中心、和别的。 2022 年,医院细分市场占据最大市场份额。预计门诊手术中心细分市场在 2022 年至 2030 年期间将实现最高的复合年增长率。医院是血管闭合装置的主要最终用户,因为它们提供广泛的医疗服务,包括需要血管通路的侵入性手术。
区域分析:
根据地理位置,血管闭合装置市场分为北半球美洲、欧洲、亚太地区、南美洲和中美洲、中东和非洲。 2022年,北美在全球血管闭合器械市场中占据最大份额。据估计,亚太地区 2022 年至 2030 年的复合年增长率最高。
预计美国将在 2022 年至 2030 年期间占据血管闭合装置市场的最大份额。该国拥有发达的医疗保健部门,拥有高度先进的设备和仪器。据报道,心血管疾病的患病率很高。根据美国心脏协会的《心脏病和中风统计数据 - 2023 年更新》,2020 年,冠心病 (CHD) 是美国 CVD 相关死亡的主要原因 (41.2%),其次是中风 (17.3%)。 %)、其他心血管疾病(16.8%)、高血压(12.9%)、心力衰竭(9.2%)和动脉疾病(2.6%)。根据美国疾病控制与预防中心 (CDC) 的数据,美国 20 岁及以上的成年人中约有二十分之一患有冠状动脉疾病。该研究还提到冠状动脉疾病是美国最常见的心脏病类型。因此,心血管疾病和冠状动脉疾病的高患病率将推动未来几年美国在外科手术中采用血管闭合装置。
美国是医疗保健领域医疗创新和技术进步的中心。微创手术相关技术的不断进步、闭合装置技术的改进以及新型闭合装置的推出有助于美国血管闭合装置市场的增长。例如,2023 年 3 月,Haemonetics Corporation(美国)向 Vivasure Medical Limited 投资约 3172 万美元(3000 万欧元)。 2023 年 3 月,Vivasure Medical 宣布 FDA IDE 批准启动一项美国关键研究,评估 Vivasure PerQseal 闭合装置系统的安全性和有效性。 2021 年,VASCADE MVP 是第一个也是唯一一个经 FDA 批准的血管闭合装置,适用于房颤 (AF) 消融术后当天出院。
行业发展和未来机会:
主要参与者的各种举措在全球血管闭合装置市场上运营的企业如下:
2023年8月,Haemonetics Corp 宣布其 VASCADE MVP 静脉血管闭合系统首次在德国用于治疗。这标志着在美国医院广泛使用的 VASCADE 系统在欧洲国家的首次使用。 2023 年 6 月,Becton Dickinson and Co. 在蒂华纳开设了一家新的制造工厂。占地 15,775 平方米的新工厂生产设备和其他产品,以提高医疗保健环境中的用药安全。 2023 年 5 月,加拿大康德乐计划在大多伦多地区开设一个新的配送中心,战略性地扩大其分销渠道,新增 9 个分销渠道地点,以更好地满足加拿大医疗保健系统的医疗和外科产品需求。2022 年 9 月,Haemonetics Corp 的 VASCADE 血管闭合器和 VASCADE MVP 静脉血管闭合系统获得了 CE 标志认证。2022 年 5 月,Teleflex Inc(全球供应商)医疗技术公司的 MANTA 血管闭合装置获得加拿大卫生部的批准,这是第一个商用生物力学血管闭合装置,专为大口径股动脉通路部位闭合而设计。此次批准标志着泰利福计划在全球范围内扩大 MANTA 可用性的计划的一个重要里程碑,随后获得适当的监管批准,从而为加拿大和世界各地的医疗保健系统提供其另一种独特设计的设备。2020 年 8 月,Vasorum Ltd与Vyyan Medical签署分销协议。根据协议,Veryan Medical 支持 Vasorum Ltd 在美国市场将 Celt ACD 商业化。此外,该协议使两家公司能够加强在美国市场的影响力。竞争格局和主要公司:
Cordis Corp、Transluminal Technologies LLC、Vasorum Ltd、Haemonetics Corp、Abbott Laboratories、Becton Dickinson and Co、Cardinal Health Inc、 ENDOCOR GmbH & CO KG、Medtronic Plc 和 Teleflex Inc 是血管闭合装置市场的知名参与者。这些公司专注于新技术、现有产品的进步和地域扩张,以满足全球不断增长的消费者需求并增加其专业产品组合的产品范围。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which procedure segment dominates the vascular closure device market?

Based on the procedure, the vascular closure device market is segmented into interventional radiology, interventional cardiology, and endovascular surgical. The interventional cardiology segment held the largest share of the market in 2022.

What are the growth estimates for the vascular closure device market till 2030?

The vascular closure device market is expected to be valued at US$ 2,804.55 million in 2030.

Which end users segment dominates the vascular closure device market?

Based on the end users, the vascular closure device market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment held the largest share of the market in 2022.

Which access segment dominates the vascular closure device market?

Based on access, the vascular closure device market has been segmented into femoral access and radial access. The femoral access segment held the largest share of the market in 2022. However, radial access is expected to register the highest CAGR in the market during 2022-2030.

Which product type segment dominates the vascular closure device market?

The vascular closure device market, by product type, is segmented into active approximators, passive approximators, and external hemostatic devices. The passive approximators segment held the largest share of the market in 2022, and it is anticipated to register the highest CAGR in the market during 2022-2030.

What are vascular closure devices?

A vascular closure device is a piece of collagen (a fibrous protein found in skin, connective tissue, and bone), a metallic clip, or a suture designed to close the small puncture produced in an artery following an angiography.

Who are the major players in the vascular closure device market?

The vascular closure device market majorly consists of the players, including Cordis Corp, Transluminal Technologies LLC, Vasorum Ltd, Haemonetics Corp, Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc, ENDOCOR GmbH & CO KG, Medtronic Plc, and Teleflex Inc.

What factors drive the vascular closure device market?

Factors such as increasing prevalence of cardiovascular diseases and burgeoning demand for minimally invasive devices propel market growth.

What was the estimated vascular closure device market size in 2022?

The vascular closure device market was valued at US$ 1,620.44 million in 2022.

The List of Companies - Vascular Closure Device Market

  1. Cordis Corp         
  2. Transluminal Technologies LLC     
  3. Vasorum Ltd        
  4. Haemonetics Corp            
  5. Abbott Laboratories          
  6. Becton Dickinson and Co              
  7. Cardinal Health Inc           
  8. ENDOCOR GmbH & CO KG         
  9. Medtronic Plc       
  10. Teleflex Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports